Membrane Structure and Function Section, Nanobiology Program, Center for Cancer Research, Bethesda, MD, USA.
Blood. 2012 Aug 9;120(6):1246-53. doi: 10.1182/blood-2011-12-399063. Epub 2012 Jul 2.
Antigen-presenting cells (APCs) act as vehicles that transfer HIV to their target CD4(+) cells through an intercellular junction, termed the virologic synapse. The molecules that are involved in this process remain largely unidentified. In this study, we used photoaffinity labeling and a proteomic approach to identify new proteins that facilitate HIV-1 transfer. We identified ectopic mitochondrial ATP synthase as a factor that mediates HIV-1 transfer between APCs and CD4(+) target cells. Monoclonal antibodies against the β-subunit of ATP synthase inhibited APC-mediated transfer of multiple strains HIV-1 to CD4(+) target cells. Likewise, the specific inhibitors of ATPase, citreoviridin and IF1, completely blocked APC-mediated transfer of HIV-1 at the APC-target cell interaction step. Confocal fluorescent microscopy showed localization of extracellular ATP synthase at junctions between APC and CD4(+) target cells. We conclude that ectopic ATP synthase could be an accessible molecular target for inhibiting HIV-1 proliferation in vivo.
抗原呈递细胞(APCs)通过细胞间连接充当将 HIV 转移到其靶 CD4(+)细胞的载体,这个连接被称为病毒突触。在此过程中涉及的分子在很大程度上尚未确定。在这项研究中,我们使用光亲和标记和蛋白质组学方法来鉴定促进 HIV-1 转移的新蛋白质。我们发现异位线粒体 ATP 合酶是一种介导 APC 和 CD4(+)靶细胞之间 HIV-1 转移的因素。针对 ATP 合酶β亚基的单克隆抗体抑制了 APC 介导的多种 HIV-1 株向 CD4(+)靶细胞的转移。同样,ATP 酶的特异性抑制剂,柠檬酸菌素和 IF1,完全阻断了 APC-靶细胞相互作用步骤中 HIV-1 的 APC 介导的转移。共聚焦荧光显微镜显示细胞外 ATP 合酶在 APC 和 CD4(+)靶细胞之间的连接处定位。我们得出结论,异位 ATP 合酶可能是一种可用于抑制体内 HIV-1 增殖的分子靶标。